XML 13 R2.htm IDEA: XBRL DOCUMENT v3.20.4
Condensed Consolidated Balance Sheets - USD ($)
Dec. 31, 2020
Mar. 31, 2020
CURRENT ASSETS    
Cash $ 3,324,190 $ 949,848
Accounts receivable, net 1,396,621 486,187
Inventory 94,848 85,720
Deposits and other receivables 126,579 137,074
Total current assets 4,942,238 1,658,829
NON-CURRENT ASSETS    
Deposits 33,000
Long-term accounts receivable 81,778 48,115
Operating lease right-of-use assets [Note 10] 115,708 264,472
TOTAL ASSETS 5,139,724 2,004,416
CURRENT LIABILITIES    
Accounts payable and accrued liabilities [Note 4] 2,633,884 1,521,689
Convertible promissory notes and short term loans [Note 5] 5,695,595 2,068,302
Operating lease obligations, current [Note 9] 113,910 213,030
Total current liabilities 8,443,389 3,803,021
NON CURRENT LIABILITIES    
Federally guaranteed loans [Note 6] 1,570,900
Derivative liabilities [Note 7] 5,833,102 1,144,733
Operating lease obligations, long term [Note 9] 57,055
TOTAL LIABILITIES 15,847,391 5,004,809
STOCKHOLDERS' DEFICIENCY    
Preferred stock, $0.001 par value, 10,000,000 authorized as at December 31 and March 31, 2020, respectively, 1 share issued and outstanding as at December 31 and March 31, 2020, respectively [Note 8] 1 1
Common stock, $0.001 par value, 125,000,000 authorized as at December 31 and March 31, 2020, respectively. Issued and outstanding common shares: 34,576,797 and 32,593,769 as at December 31 and March 31, 2020, respectively, and exchangeable shares of 3,219,518 and 3,788,062 as at December 31 and March 31, 2020 [Note 8] 37,797 36,382
Shares to be issued (339,500 and 178,750 shares of common stock as at December 31 and March 31, 2020, respectively) [Note 8] 250,715 169,490
Additional paid-in-capital 46,707,203 44,015,397
Accumulated other comprehensive loss (670,060) (857,307)
Accumulated deficit (57,033,331) (46,364,364)
TOTAL STOCKHOLDERS' DEFICIENCY (10,707,667) (3,000,393)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIENCY 5,139,724 2,004,416
Series A Preferred Stock [Member]    
STOCKHOLDERS' DEFICIENCY    
Preferred stock, $0.001 par value, 10,000,000 authorized as at December 31 and March 31, 2020, respectively, 1 share issued and outstanding as at December 31 and March 31, 2020, respectively [Note 8] $ 8 $ 8